This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Why Do We Adjust Index Divisor covers the core reasons behind adjustments, including corporate actions and market events, and how they affect benchmarks.
20,620 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Looking for steady income in a volatile market? This guide highlights three high-yield energy stocks march investors ...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
A Nurix Therapeutics insider recently sold shares, drawing attention from investors. This article breaks down the mov...
Oklo stock climbing higher this week is driven by regulatory progress on its Aurora reactor and broader interest in a...
A big jump in ezcorp stock 130% has investors buzzing. This piece explains what happened, why an investor sold millio...
Fermi’s stock jump today highlights how earnings, project milestones, and strategic pivots shape appetite for AI infr...
A major move by Qualcomm leadership could alter the stock's trajectory. This article breaks down the implications, pr...
When a legendary investor signals confidence, investors listen. This article delves into why this unstoppable stock s...
A policy push to cover GLP-1 drugs for weight loss under Medicare stalled, leaving many beneficiaries in the middle. ...
A large stake exit sent shockwaves through a payments stock, pulling it down by about half from its highs. This artic...
As robotaxi plans advance, Tesla stock faces a critical test. This article explains why tesla stock gets wall Street ...